Nonoperative management of main pancreatic duct–involved intraductal papillary mucinous neoplasm might be indicated in select patients

AM Roch, JM DeWitt, MA Al-Haddad… - Journal of the American …, 2014 - Elsevier
Background Although the natural history of intraductal papillary mucinous neoplasm (IPMN)
remains unclear, large surgical series have reported malignancy in 40% to 90% of main …

Main-duct intraductal papillary mucinous neoplasm: high cancer risk in duct diameter of 5 to 9 mm

T Hackert, S Fritz, M Klauss, F Bergmann… - Annals of …, 2015 - journals.lww.com
Objective: The 2012 international consensus guidelines for the management of intraductal
papillary mucinous neoplasms (IPMN) recommend surgical treatment in main-duct IPMN …

Assessment of a revised management strategy for patients with intraductal papillary mucinous neoplasms involving the main pancreatic duct

M Sugimoto, IA Elliott, AH Nguyen, S Kim… - JAMA …, 2017 - jamanetwork.com
Importance According to the 2012 International Consensus Guidelines, the diagnostic
criterion of intraductal papillary mucinous neoplasms (IPMNs) involving the main duct (MD …

Does preoperative cross-sectional imaging accurately predict main duct involvement in intraductal papillary mucinous neoplasm?

MR Barron, AM Roch, JA Waters, JA Parikh… - Journal of …, 2014 - Elsevier
Main pancreatic duct (MPD) involvement is a well-demonstrated risk factor for malignancy in
intraductal papillary mucinous neoplasm (IPMN). Preoperative radiographic determination of …

Potential predictors of disease progression for main‐duct intraductal papillary mucinous neoplasms of the pancreas

T Ogura, D Masuda, Y Kurisu… - Journal of …, 2013 - Wiley Online Library
Abstract Background and Aim The evidence for main pancreatic duct intraductal papillary
mucinous neoplasms (MPD‐IPMN) malignancy is based predominantly on investigation of …

Validation of the 2012 international consensus guidelines using computed tomography and magnetic resonance imaging: branch duct and main duct intraductal …

N Seo, JH Byun, JH Kim, HJ Kim, SS Lee… - Annals of …, 2016 - journals.lww.com
Objective: To validate the 2012 guidelines for intraductal papillary mucinous neoplasm
(IPMN) of the pancreas and to compare diagnostic performances of computed tomography …

[HTML][HTML] Validation of international consensus guideline 2012 for intraductal papillary mucinous neoplasm of pancreas

DH Han, H Lee, JY Park, W Kwon, JS Heo… - Annals of Surgical …, 2016 - ncbi.nlm.nih.gov
Purpose Intraductal papillary mucinous neoplasm (IPMN) has variable malignant potential
ranging from premalignant intraductal lesions to malignant neoplasms with invasive …

IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection

G Marchegiani, M Mino-Kenudson, K Sahora… - Annals of …, 2015 - journals.lww.com
Objectives: To describe the characteristics of intraductal papillary mucinous neoplasms
(IPMNs) with predominant involvement of the main pancreatic duct (MPD), analyzing …

Surgical strategy for main pancreatic duct-type intraductal papillary mucinous neoplasm of the pancreas

T Kuroki, T Adachi, O Shinichiro… - …, 2012 - nagasaki-u.repo.nii.ac.jp
Background/Aims: Although surgical resection is recommended for all main duct-type
intraductal papillary mucinous neoplasms (IPMNs), controversies remain over the precise …

Prevalence of malignancy in patients with pure main duct intraductal papillary mucinous neoplasms

K Abdeljawad, KC Vemulapalli, CM Schmidt… - Gastrointestinal …, 2014 - Elsevier
Background Risk of malignancy in main duct intraductal papillary mucinous neoplasm (MD-
IPMN) ranges from 36% to 100% in the literature. Although surgical resection is …